CAMBRIDGE, England, October 16, 2024--bit.bio, the company coding human cells for novel cures and a pioneer in synthetic biology, today announces the successful defence of its foundational European ...

bit.bio, the company coding human cells for novel cures and a pioneer in synthetic biology, today announces the successful defence of its foundational European patent for opti-ox, a breakthrough ...

The issuer is solely responsible for the content of this announcement.

FORT LAUDERDALE, FL / ACCESSWIRE / October 15, 2024 / ZEO ScientifiX, Inc. ('ZEO' or the 'Company') (OTCQB:ZEOX), a South Florida-based clinical-stage biopharmaceutical company, announced the launch ...

Best Stocks to Invest in Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...

NEW YORK, NY, UNITED STATES, October 11, 2024 /EINPresswire / -- Akelos Inc., a biotechnology company currently developing and commercializing a no ...

BOSTON, Oct. 11, 2024 /PRNewswire/ -- "According to the latest BCC research study, the demand for Global Automated and Closed Cell Therapy Market is expected to grow from $1.8 billion in 2024 and is ...

Work at Reactive Biosciences Inc. has led to the discovery of new phosphatidylinositol 3-kinase α (PI3Kα) (H1047R mutant) inhibitors reported to be useful for the treatment of cancer.

Trump’s promise to impose taxes of 10-20 percent on all imports (more for imports from China) has put protectionism front and ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

Domestic pharmaceutical companies say losing patent rights flexibilities will make medicines more expensive, as producing ...

In two new papers, both published in Cell Reports Medicine, researchers from the University of Michigan Rogel Cancer Center ...